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LARF: Instrumental Variable Estimation of Causal






LARF is an R package that provides instrumental variable estimation of treatment ef-
fects when both the endogenous treatment and its instrument (i.e., the treatment induce-
ment) are binary. The method (Abadie 2003) involves two steps. First, pseudo-weights
are constructed from the probability of receiving the treatment inducement. By default
LARF estimates the probability by a probit regression. It also provides semiparametric
power series estimation of the probability and allows users to employ other external meth-
ods to estimate the probability. Second, the pseudo-weights are used to estimate the local
average response function conditional on treatment and covariates. LARF provides both
least squares and maximum likelihood estimates of the conditional treatment effects.
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1. Introduction
We created the package LARF (An and Wang 2015) in R (R Core Team 2016) to implement
the method proposed by Abadie (2003) that provides instrumental variable (IV) estimation of
causal effects when both the endogenous treatment and its instrument are binary. The main
strength of the method is that it can address treatment selection without the imposition of
parametric identifying assumptions.
The method is based on the potential outcomes framework (Rubin 1974, 1977). Suppose
we are interested in estimating the average effect of a binary treatment D on outcome Y ,
namely, E[Y1−Y0]. The term Y1 represents the potential outcome if an individual receives the
treatment while Y0 the potential outcome if the individual does not receive the treatment. The
average treatment effect (ATE) can also be viewed as a weighted average: πE[Y1 − Y0|D =
1] + (1 − π)E[Y1 − Y0|D = 0], where π and 1 − π are the proportions of the treated and
the control units in the population, respectively. E[Y1 − Y0|D = 1] represents the average
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treatment effect on the treated (ATT) and E[Y1 − Y0|D = 0] the average treatment effect on
the control (ATC). In a naive way, we may use the difference between the average outcomes
of the treated group and the control group (i.e., E[Y1|D = 1]− E[Y0|D = 0]) to estimate the
ATE. However, it is shown that this naive estimator is biased (Morgan and Winship 2014).
E[Y1|D = 1]− E[Y0|D = 0]− E[Y1 − Y0]
= E[Y0|D = 1]− E[Y0|D = 0] + (1− π)(ATT−ATC).
The bias can arise from two sources: outcome differences across the treatment groups in the
absence of treatment and differential treatment effects for the treated and the control. The
bias tends to be present if units which expect to benefit from the treatment select to take
the treatment while units which expect not to benefit or benefit less reject the treatment.
Similarly, we can show that this estimator is biased for estimating either ATT or ATC.
When there is a randomized treatment inducer Z, which is imperfectly correlated with the
treatment intake D, Imbens and Angrist (1994) and Angrist, Imbens, and Rubin (1996)
show that under mild assumptions, local average treatment effect (LATE) for compliers (i.e.,
individuals for whom D = 1 if Z = 1, and D = 0 if Z = 0) can be identified by instrumenting
the treatment intake D by the treatment inducer Z. Abadie (2003) extended the previous
methods by allowing the treatment inducer to be randomized conditionally on the covariates
and by allowing the outcome to depend on the covariates besides the treatment intake. Abadie
(2003) also provided semiparametric estimations of the probability of receiving the treatment
inducement, which helps to identify the treatment effects in a more robust way.
Specifically, when the treatment inducer Z is as good as randomized after conditioning on
covariates X, Abadie (2003) proposed a two-stage procedure to estimate treatment effects. In
the first step, it estimates the probability of receiving the treatment inducement P(Z = 1|X)
in order to provide a set of pseudo-weights. Second, the pseudo-weights are used to estimate
the local average response function (LARF) of the outcome conditional on the treatment
and covariates. The estimated coefficient for the treatment intake D reflects the conditional
treatment effect.
The main function larf in the LARF package implements the method proposed in Abadie
(2003). The package is available from the Comprehensive R Archive Network (CRAN) at
https://CRAN.R-project.org/package=LARF.
This paper proceeds as follows. In Section 2, we sketch the statistical theories behind LARF.
In Section 3, we demonstrate the usage of LARF with both simulated and empirical examples.
In Section 4, we compare our package with similar programs.
2. Estimation of treatment effects through LARF
2.1. Identification of treatment effect for compliers
Suppose there is a binary treatment inducer Z, which is as good as randomized after condi-
tioning on the covariates. Using Dz to indicate the potential treatment intake when Z = z,
we can divide the units into four groups. The first group contains compliers, i.e., those who
will comply with their treatment inducement. If they are induced to take the treatment (i.e.,
z = 1), they will take the treatment (i.e., D1 = 1). If they are induced into the control
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Treatment intake D
Treatment inducement Z 0 1
0 (1) Compliers, Never Takers (2) Always Takers, Defiers
1 (3) Never Takers, Defiers (4) Compliers, Always Takers
Table 1: Dividing units into four groups by treatment inducement and intake.
condition (i.e., z = 0), they will not take the treatment (i.e., D0 = 0). In other words, for this
group, D1 > D0. The second group is always-takers who will take the treatment regardless of
the treatment inducement, i.e., D1 = D0 = 1. The third group is never-takers who will not
take the treatment whatsoever, i.e., D1 = D0 = 0. The last group is defiers who will do the
opposite to their treatment inducement. If they are induced to take the treatment, they will
opt out. But if they are induced not to take the treatment, they will opt in. Thus for this
group, D1 < D0. Table 1 shows the breakdown of the four groups.
Based on Angrist et al. (1996), Abadie (2003) listed a set of assumptions for the proposed IV
method to identify treatment effects. With slight adaption we present them below.
i) Conditional ignorability: (Ydz, Dz)⊥Z|X, namely, conditioning on X, the potential out-
comes Y and the potential treatment intake D are independent of Z. In other words, Z
is as good as randomly assigned conditional on covariates X.
ii) Exclusion of the instrument: P(Yd1|D = d,X = x) = P(Yd0|D = d,X = x). This
means that Z has no direct effects on Y once actual treatment intake and covariates are
controlled for. The first two assumptions ensure the exogeneity of Z.
iii) Relevance of the instrument: COV(D,Z) 6= 0, namely, Z is predictive of D. The first
three assumptions ensure that Z can serve as a valid instrument for D.
iv) Common support: 0 < P(Z = 1|X) < 1, namely, not all units with certain covariates are
induced to take or not to take the treatment.
v) Monotonicity: P(D1 ≥ D0|X) = 1. This assumption ensures there are no defiers.1
Given the monotonicity assumption, we can identify the proportion of compliers, always-takers
and never-takers, respectively.
πcompliers : P(D1 > D0|X) = E[D|X,Z = 1]− E[D|X,Z = 0], (1)
πalways-takers : P(D1 = D0 = 1|X) = E[D|X,Z = 0], (2)
πnever-takers : P(D1 = D0 = 0|X) = 1− E[D|X,Z = 1]. (3)
Let g be a measurable real function of (Y,D,X) such that E|g(Y,D,X)| <∞. We can show
that the expectation of g is a weighted sum of the expectations of g in the three groups.
E[g|X] = E[g|X,D1 > D0]P(D1 > D0|X) + E[g|X,D1 = D0 = 1]P(D1 = D0 = 1|X)
+ E[g|X,D1 = D0 = 0]P(D1 = D0 = 0|X). (4)
1Although the monotonicity assumption may hold generally, it needs to be assessed case by case. It is
worth noting that some prior work has attempted to relax this assumption, for examples, Shepherd, Redman,
and Ankerst (2008) and Small, Tan, Lorch, and Brookhart (2014).
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Rearranging the terms in (4) and plugging in the group proportions, Abadie (2003) shows











Integrating out X (see page 258 of Abadie 2003), we get











= 1P(D1 > D0)
E [gκ] ,
where
κ = 1− D(1− Z)P(Z = 0|X) −
(1−D)Z
P(Z = 1|X) .
The results shows that, the joint distribution of (Y,D,X) is identifiable for compliers if we use
the κ as a set of pseudo weights. Since for compliers there is no treatment selection problem,
we can also identify the treatment effect of D on Y .
2.2. Estimation of the pseudo weights
In order to estimate the pseudo weights κ, it is necessary to estimate P(Z = 1|X), i.e., the
probability of receiving the treatment inducement. Abadie (2003) proposed two methods to
estimate P(Z = 1|X). One is based on a probit model, namely, P(Z = 1|X) = Φ(X>γ).
The predicted probability along with D are then used to calculate κ. The probability P(Z =
1|X) can also be estimated by a semiparametric power series method (Abadie 2003, p. 243;
Mercatanti and Li 2014). In brief, the semiparametric power series method uses the power
series of the covariates to predict the probability of receiving the treatment inducement. The
optimal order of the power series can be determined by cross-validations. Relatively speaking,
the power series method is more robust to potential model specification errors. In the package,
we implement both the probit and the power series methods. See Section 3 for examples.
2.3. Estimation of the local average response function
Define E[Y |X,D,D1 > D0] as the local average response function for the compliers (LARF).
By construction, the results for g shown above are also applicable to the LARF. Abadie
(2003) proposed two methods to estimate the LARF: One is based on the weighted least
squares method (LS) and the other based on maximum likelihood (ML) estimation.
Suppose E[Y |X,D,D1 > D0] = h(D,X; θ). Given the results in Section 2.1 and the avail-
ability of κ, the parameter vector θ0 in the LS estimator is
θ0 = argmin
θ∈Θ
E[κ (Y − h(D,X; θ))2]. (6)
Let A = (D,X) and θ = (α;β). In LARF, for continuous outcomes h = A>θ = (αD+X>β).
For binary outcomes, h = Φ(A>θ) = Φ(αD +X>β).
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LARF also provides ML estimates. For continuous outcomes, Y − (αD + X>β) is assumed
to follow a Normal distribution with a variance σ2. Then
θ0 = argmax
θ∈Θ
E[κ {− ln(σ)− 12σ2 (Y − (αD +X
>β))2}]. (7)
For binary outcomes, Y is approximated by a probit function. Then we have
θ0 = argmax
θ∈Θ
E[κ {Y ln Φ(αD +X>β) + (1− Y ) ln Φ(−αD −X>β)}]. (8)
The variances of the coefficients in LARF are estimated according to Theorem 4.2 in Abadie
(2003) if the probability of receiving treatment inducement is estimated by a probit model.
The variances are estimated according to Theorem 4.5 in Abadie (2003) if the probability of
receiving treatment inducement is estimated by the power series method.
3. Package overview and examples
3.1. Usage of the LARF
The larf function in LARF implements the aforementioned methods. Its basic usage is:
larf(formula, treatment, instrument, data, method = "LS", AME = FALSE,
optimizer = "Nelder-Mead", zProb = NULL)
where the arguments are defined as follows.
• formula: specification of the outcome model in the form like either y ~ x1 + x2 or
y ~ X where X is a matrix containing all the covariates excluding the treatment. Also
support multi-part formulas (Zeileis and Croissant 2010). For example, y + d ~ x1 +
x2 | z, where d represents the treatment and z the instrument.
• treatment: a vector containing the binary treatment.
• instrument: a vector containing the binary instrument for the endogenous treatment.
• data: an optional data frame. If unspecified, the data will be taken from the working
environment.
• method: the estimation method to be used. The default is "LS", standing for least
squares. "ML", standing for maximum likelihood, is an alternative.
• AME: whether average marginal effects (AME) should be reported. The default is FALSE,
in which case marginal effects at the means (MEM) are reported.
• optimizer: the optimization algorithm for the ML method. It should be one of
"Nelder-Mead", "BFGS", "CG", "L-BFGS-B", "SANN", or "Brent". See optim in R for
more detail.
• zProb: a vector containing the probability of receiving the treatment inducement that
has been estimated externally.
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The larf function returns the estimated coefficients for the treatment and covariates and
their standard errors. For binary outcomes, it also returns the marginal effects at the means
(MEM) or the average marginal effects (AME) if requested.2 larf is the high-level interface
to the work-horse function larf.fit. A set of standard methods (including print, summary,
vcov, and predict) can be used to extract the corresponding information from a ‘larf’
object. For more detail, please see ?larf.fit.
3.2. Simulations
We conduct simulations to show the properties of the LARF method. The equations we used
to generate the data are as follows.
Y ∗ = αD +X>β + e, (9)
D∗ = (Z, X)>γ + v. (10)
The covariates include X1 and X2 and are generated according to
X1i ∼ Normal(0, 1),
X2i ∼ Normal(0, 2).
The treatment inducer Z is generated according to
Zi ∼ Bernoulli(0.5).













We then generateD∗i = −0.1+0.7Zi+0.3X1i−0.5X2i+vi. We viewD∗i as the latent probability
of receiving the treatment. Corresponding to a probit model, the observed treatment intake
Di is then set to one if D∗i is larger than zero and to zero otherwise.3 We generate the latent
outcome Y ∗i = −0.2 + 0.8D+ 0.4X1i− 0.6X2i + ei. Similarly, we set the observed outcome Yi
to one if Y ∗i is larger than zero and to zero otherwise.
The correlation in the error terms leads the treatment D to be correlated with e. Thus a
simple regression of the outcome on D and the covariates will lead to biased estimates of the
treatment effects. Since Z is randomly assigned and is uncorrelated with the outcome except
via its correlation with the treatment, it can be used as an instrument for D to estimate the
treatment effect.
2Marginal effect at the means for a continuous variable is the partial derivative of the outcome with respect
to the variable evaluated at the means of other variables, i.e., φ(Ā>θ̂)θ̂. For a binary variable C, it is the
change in the probability when the variable is changed from zero to one while holding other variables at their
means, i.e., Φ(Ā>θ̂|C = 1) − Φ(Ā>θ̂|C = 0). Average marginal effect is the average of individual marginal
effects, i.e., E[φ(A>θ̂)]θ̂. Average marginal effect for a binary variable is the average change in the probability
when the variable is changed from zero to one, i.e., E[Φ(A>θ̂|C = 1)−Φ(A>θ̂|C = 0)]. These marginal effects
are widely used in social sciences. But it is worth noting that the term “marginal effects" has been used
differently, for example, to refer to the treatment effects estimated by weighting regressions with the inverse
probability of treatment (Bang and Robins 2005; Lunceford and Davidian 2004).
3This is the latent variable approach to motivating the probit model, where P(D∗i > 0) = P(Di = 1).
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Naive LARF 2SLS
Outcome Bias MSE Bias MSE Bias MSE
Continuous 1.25 1.56 −0.02 0.04 −0.02 0.04
Binary 1.78 3.19 0.52 0.30 −0.37 0.14
Table 2: Results of the simulations. Note: Rows 1 and 2 show the simulation results for
continuous outcomes and binary outcomes, respectively. Bias is the 10% trimmed mean of
(estimates − 0.8). Namely, 10% of very large or very small estimates are removed before
calculating the mean deviation in order to reduce the influence of outliers. MSE is the mean-
square-error. Columns (1) and (2) show the results when the outcomes are directly predicted
from the treatment and covariates. Columns (3) and (4) show the results of the LARF
estimates. Columns (5) and (6) show the results of the 2SLS estimates.
We conduct two sets of simulations. First, we treat the latent outcome Y ∗ as a observed
continuous outcome. Second, we treat Y as the observed binary outcome. For comparison,
we also provide naive estimates based on ordinary least squares (OLS) for the continuous
outcome and probit for the binary outcome and corresponding estimates based on two-stage
least squares (2SLS). We set the sample size at 2,000 and conduct 500 rounds of simulations
for each type of outcome. The results are shown in Table 2.
When the outcome is continuous, the naive estimation has both much larger bias and mean-
squared-error (MSE) than the LARF and the 2SLS estimations. Between LARF and 2SLS
estimations, there are no discernible differences. When the outcome is binary, the naive esti-
mation also has much larger bias and MSE than LARF and 2SLS. There is also little evidence
that one is qualitatively better than the other between LARF and 2SLS. This happens maybe
because we have a constant treatment effect. If there is effect heterogeneity, LARF may per-
form better than 2SLS. In addition, LARF allows covariates to have nonlinear effects on the
outcome, which is an attractive feature in many contexts. Although the above results are
based on a specific simulation, the patterns of the results should hold generally because the
simulation has a general structure.
3.3. An empirical example
We show an empirical example using the data on eligibility for and participation in 401(k)
from the Wooldridge data sets (Wooldridge 2010).4 The basic research questions are to what
extent participation in 401(k) – usually an employer-sponsored retirement saving plan, affects
individuals’ net family financial assets and participation in other retirement saving plans
(e.g., Individual Retirement Accounts (IRA)). Because individuals may selectively participate
in 401(k) due to their different unobserved preferences for savings, the naive estimate of
the treatment effect by comparing the average outcomes between the participants and non-
participants of 401(k) may be biased.
The data includes both a continuous outcome on net family financial assets (nettfa) and
a binary outcome on participation in IRA (pira). The treatment is participation in 401(k)
(p401k). Eligibility for 401(k), e401k, is used as an instrument for participation in 401(k).
4The data is entitled 401ksubs.dta in Stata (StataCorp. 2015) format, available at http://www.stata.
com/texts/eacsap/. Based on the summary statistics of the data, it appears to be the same data used in
Poterba, Venti, and Wise (1995), Poterba, Venti, and Wise (1997), and Abadie (2003).
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Entire sample Participants Non-
participants
Variables Mean SD Mean SD Mean SD p
Participation in 401(k) (binary) 0.28 0.45
Eligibility for 401(k) (binary) 0.39 0.49 1.00 0.00 0.16 0.37 0.00
Participation in IRA (binary) 0.25 0.44 0.36 0.48 0.21 0.41 0.00
Married (binary) 0.63 0.48 0.70 0.46 0.60 0.49 0.00
Family net financial assets ($1000) 19.07 63.96 38.47 79.27 11.67 55.29 0.00
Family income ($1000) 39.25 24.09 49.82 26.81 35.22 21.65 0.00
Age (continuous) 41.08 10.30 41.51 9.65 40.91 10.53 0.01
Family Size (count) 2.89 1.53 2.92 1.47 2.87 1.55 0.17
N 9275 6713 2562
Table 3: Summary statistics of the data. Note: The data is obtained from the Wooldridge
data sets (Wooldridge 2010), available at http://www.stata.com/texts/eacsap/. The type
of data is shown after each variable’s name. The first four variables are binary. Thus their
means can be interpreted as proportions. For example, the mean of “Married” is 0.63, which
indicates 63% of the subjects are married. Its standard deviation equals 0.48, i.e., the square
root of 0.37 × (1 − 0.37). Participants are those who have participated in 401(k) while non-
participants are those who have not enrolled in 401(k). The last column shows the p values
of the t-tests that test whether the means of the covariates between the participants and
non-participants are equal.
Since an individual has to be eligible for 401(k) to participate in it, there are neither defiers
nor always-takers in this case. Because 401(k) eligibility is determined by employers, it is
likely independent of employees’ unobserved preferences for savings. To what extent 401(k)
eligibility can legitimately serve as an instrument for participation in 401(k), however, is
debatable (Engen, Gale, and Scholz 1994; Poterba et al. 1995). But for illustrative purposes,
following Abadie (2003), we assume that it can be used as an instrument for participation in
401(k). Table 3 presents the summary statistics of the data.5
To demonstrate the usage of larf, we load the package LARF and the data c401k.
R> library("LARF")
R> data("c401k", package = "LARF")
R> attach(c401k)
We first estimate the effect of participation in 401(k) on the net family financial assets
(nettfa, continuous). The covariates include an intercept, family income, age, age2, marital
status, and family size. We instrument participation in 401(k) by 401(k) eligibility.
R> est1 <- larf(nettfa ~ inc + age + agesq + marr + fsize, treatment = p401k,
+ instrument = e401k, data = c401k)
R> summary(est1)
Call:
larf(formula = nettfa ~ inc + age + agesq + marr + fsize, treatment = p401k,
5Similar summary statistics for the same data can be found in Table 1 of Abadie (2003).
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instrument = e401k, data = c401k)
Estimate SE P
Treatment 9.4947 2.1582 0.0000
(Intercept) -7.6793 14.8525 0.6051
inc 1.0130 0.0908 0.0000
age -1.4790 0.8047 0.0661
agesq 0.0308 0.0099 0.0020
marr -7.4821 2.5607 0.0035
fsize -1.0573 0.6262 0.0913
The results show that holding everything else constant, participation in 401(k) increases family
net financial assets by about 9.49 thousand dollars on average (SE = 2.16 $1,000, p < 0.001).
By default the above calculation estimates the probability of being eligible for 401(k) using a
probit model. To check the robustness of the results, we also estimate the probability using
a semiparametric power series method (Abadie 2003; Mercatanti and Li 2014). We set the
maximal order of the covariates power series to be 5. After running npse we find the optimal
order of power series is 2 based on cross-validations.
R> ps <- npse(e401k ~ inc + age + agesq + marr + fsize, order = 5)
R> ps$Lambda
[1] 2
Then we use the optimal order of covariates power series to predict the probability of being
eligible for 401(k) and use the predict probability to estimate the treatment effect in larf.
R> est2 <- larf(nettfa ~ inc + age + agesq + marr + fsize, treatment = p401k,
+ instrument = e401k, data = c401k, zProb = ps$fitted)
R> summary(est2)
Call:
larf(formula = nettfa ~ inc + age + agesq + marr + fsize, treatment = p401k,
instrument = e401k, data = c401k, zProb = ps$fitted)
Estimate SE P
Treatment 12.3388 5.9162 0.0370
(Intercept) -26.3848 52.7782 0.6171
inc 0.8905 0.3174 0.0050
age -0.4038 2.9795 0.8922
agesq 0.0180 0.0358 0.6151
marr -5.5235 6.0013 0.3574
fsize -1.3495 1.7367 0.4371
The results show that holding everything else constant, participation in 401(k) increases
net family financial assets by about 12.34 thousand dollars on average (SE = 5.92 $1,000,
p < 0.05). Hence, the main finding seems to be quite robust.
We then estimate the effect of participating in 401(k) on the possession of an IRA account.
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R> est3 <- larf(pira ~ inc + age + agesq + marr + fsize, p401k, e401k,
+ data = c401k)
R> summary(est3)
Call:
larf(formula = pira ~ inc + age + agesq + marr + fsize, treatment = p401k,
instrument = e401k, data = c401k, AME = FALSE)
Estimate SE P MEM MEM-SE MEM-P
Treatment 0.0788 0.0501 0.1157 0.0254 0.0161 0.1144
(Intercept) -3.5598 0.4673 0.0000 -0.7428 0.0092 0.0000
inc 0.0202 0.0012 0.0000 0.0065 0.0004 0.0000
age 0.0801 0.0225 0.0004 0.0257 0.0072 0.0003
agesq -0.0005 0.0003 0.0351 -0.0002 0.0001 0.0342
marr 0.1292 0.0701 0.0654 0.0410 0.0219 0.0614
fsize -0.1268 0.0231 0.0000 -0.0407 0.0074 0.0000
The first two columns show the estimated coefficients and standard errors. Columns (4) and
(5) show the marginal effects at the means and their standard errors. The results suggest
that participation in 401(k) increases the probability of participation in IRA by 0.025 (SE =
0.016). But the effect is not statistically significant at the 5% level.6 We also estimate the
average marginal effects. Again, there is no significant evidence that participation in 401(k)
crowds out IRA participation.
R> est4 <- larf(pira ~ inc + age + agesq + marr + fsize, p401k, e401k,
+ data = c401k, AME = TRUE)
R> summary(est4)
Call:
larf(formula = pira ~ inc + age + agesq + marr + fsize, treatment = p401k,
instrument = e401k, data = c401k, AME = TRUE)
Estimate SE P AME AME-SE AME-P
Treatment 0.0788 0.0501 0.1157 0.0218 0.0139 0.1167
(Intercept) -3.5598 0.4673 0.0000 -0.7171 0.0104 0.0000
inc 0.0202 0.0012 0.0000 0.0055 0.0003 0.0000
age 0.0801 0.0225 0.0004 0.0219 0.0061 0.0004
agesq -0.0005 0.0003 0.0351 -0.0001 0.0001 0.0348
marr 0.1292 0.0701 0.0654 0.0352 0.0190 0.0641
fsize -0.1268 0.0231 0.0000 -0.0347 0.0062 0.0000
We also estimate the effects of participation in 401(k) on family net financial assets by OLS
and 2SLS and on IRA participation by probit, 2SLS, IV probit, and bivariate probit. The
6We confirmed that both our LARF estimates were the same as those estimated by Abadie’s code in
MATLAB (available at http://www.hks.harvard.edu/fs/aabadie/larf.html). These estimates are slightly
different from those shown in Abadie (2003), probably because the latter calculated the marginal effects at the
covariate means of the treated units.
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A. Family net financial assets (continuous) Coef. SE
OLS 13.527 1.810 ***
2SLS 9.419 2.152 ***
LARF 9.495 2.158 ***
B. IRA participation (binary) MEM SE
Probit 0.062 0.011 ***
2SLS 0.027 0.013 **
IV probit 0.110 0.047 **
Bivariate probit 0.031 0.012 ***
LARF 0.025 0.016
Table 4: Effects of participation in 401(k). Note: The data is from the Wooldridge data sets
(Wooldridge 2010), available at http://www.stata.com/texts/eacsap/. The dependent
variables are net family financial assets and participation in IRA, respectively. The covariates
include a constant, participation in 401(k), family income, age, age square, marital status, and
family size. Participation in 401(k) is instrumented by eligibility for 401(k). Panel A shows
the estimated coefficients for the treatment, which reflect the average increase in family net
financial assets when a person participates in 401(k) while holding everything else constant.
Panel B shows the marginal effects for the treatment while holding other covariates at their
means, which reflect the change in probability of participating IRA when an average person
participates in 401(k). Significance level: *, p < 0.10; **, p < 0.05; ***, p < 0.01.
results are shown in Table 4. For net family financial assets, both the 2SLS and the LARF
estimates are much smaller than the OLS estimate, suggesting that the latter may have been
biased upwardly by treatment selection. For IRA participation, the LARF estimate is the
only one that is not statistically significant at the 5% level, i.e., the only one that is not in
conflict with the theoretical prediction. These estimates are only for illustrative purposes, as
models with different covariates will render maybe somewhat different results.
4. Comparison with similar programs
LARF fills an important gap in IV estimations. Programs like systemfit (Henningsen and
Hamann 2015, 2007) in R and ivregress (StataCorp. 2015) and ivregress2 (Wada 2012) in
Stata have been widely used for IV estimations. They fit linear regressions and work well if
both the outcome and the endogenous treatment are continuous. But if the dependent variable
is binary, the predictions can be inappropriately outside of (0, 1).7 ivprobit (StataCorp.
2015) in Stata works for binary outcomes, but still requires a continuous treatment. The
bivariate probit model (e.g., biprobit (StataCorp. 2015) in Stata and binom2.rho of VGAM
(Yee 2015a,b) in R) can estimate causal effects with binary endogenous treatment, but it
requires the outcome to be binary and also (sometimes unrealistically) assumes that the joint
distribution for the outcome and the treatment is correctly known. In short, when both the
endogenous treatment and its instrument are binary, LARF can provide more appropriate
estimations of treatment effects for both continuous and binary outcomes.
7Note that when the treatment inducer is binary and fully randomized, the predicted outcome by ivregress
or ivregress2 will be within the range (0, 1) (Angrist et al. 1996).
12 LARF: Local Average Response Functions
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